GB201802353D0 - Treatment of chronic obstructive pulmonary disease - Google Patents
Treatment of chronic obstructive pulmonary diseaseInfo
- Publication number
- GB201802353D0 GB201802353D0 GBGB1802353.1A GB201802353A GB201802353D0 GB 201802353 D0 GB201802353 D0 GB 201802353D0 GB 201802353 A GB201802353 A GB 201802353A GB 201802353 D0 GB201802353 D0 GB 201802353D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- treatment
- pulmonary disease
- chronic obstructive
- obstructive pulmonary
- chronic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (14)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1802353.1A GB201802353D0 (en) | 2018-02-13 | 2018-02-13 | Treatment of chronic obstructive pulmonary disease |
JP2020531614A JP7372680B2 (en) | 2017-12-11 | 2018-12-11 | Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations of chronic obstructive pulmonary disease. |
HUE18819366A HUE054266T2 (en) | 2017-12-11 | 2018-12-11 | Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention of acute exacerbations of chronic obstructive pulmonary disease |
ES18819366T ES2882978T3 (en) | 2017-12-11 | 2018-12-11 | Use of 3- [5-amino-4- (3-cyanobenzoyl) -pyrazol-1-yl] -N-cyclopropyl-4-methylbenzamide in the prevention of acute exacerbations of chronic obstructive pulmonary disease |
EP18819366.8A EP3585383B1 (en) | 2017-12-11 | 2018-12-11 | Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention of acute exacerbations of chronic obstructive pulmonary disease |
PL18819366T PL3585383T3 (en) | 2017-12-11 | 2018-12-11 | Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention of acute exacerbations of chronic obstructive pulmonary disease |
PT188193668T PT3585383T (en) | 2017-12-11 | 2018-12-11 | Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations of chronic obstructive pulmonary disease |
PCT/GB2018/053591 WO2019116022A1 (en) | 2017-12-11 | 2018-12-11 | Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations of chronic obstructive pulmonary disease |
EP21156673.2A EP3845228A1 (en) | 2017-12-11 | 2018-12-11 | Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations of chronic obstructive pulmonary disease |
CA3085544A CA3085544A1 (en) | 2017-12-11 | 2018-12-11 | Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations of chronic obstructive pulmonary disease |
US15/733,213 US11234967B2 (en) | 2017-12-11 | 2018-12-11 | Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations of chronic obstructive pulmonary disease |
AU2018381874A AU2018381874A1 (en) | 2017-12-11 | 2018-12-11 | Use of 3-(5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl)-N-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations of chronic obstructive pulmonary disease |
KR1020207019714A KR20200097310A (en) | 2017-12-11 | 2018-12-11 | Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbation of chronic obstructive pulmonary disease |
DK18819366.8T DK3585383T3 (en) | 2017-12-11 | 2018-12-11 | USE OF 3- [5-AMINO-4- (3-CYANOBENZOYL) -PYRAZOL-1-YL] -N-CYCLOPROPYL-4-METHYLBENZAMIDE IN THE PREVENTION OF ACUTE EXTENSIONS OF CHRONIC OBSTRUCTIVE |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1802353.1A GB201802353D0 (en) | 2018-02-13 | 2018-02-13 | Treatment of chronic obstructive pulmonary disease |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201802353D0 true GB201802353D0 (en) | 2018-03-28 |
Family
ID=61731331
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1802353.1A Ceased GB201802353D0 (en) | 2017-12-11 | 2018-02-13 | Treatment of chronic obstructive pulmonary disease |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB201802353D0 (en) |
-
2018
- 2018-02-13 GB GBGB1802353.1A patent/GB201802353D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL289650A (en) | Azolopyrimidine for the treatment of cancer-related disorders | |
IL273693A (en) | Treatment of inflammatory disorders | |
IL279260A (en) | Kdm1a inhibitors for the treatment of disease | |
GB201500314D0 (en) | Pharmaceutical formulations for the treatment of pulmonary arterial hypertension | |
SG11202000893QA (en) | Use of inhaled nitric oxide for the treatment of pulmonary hypertension associated with lung disease | |
EP3897641C0 (en) | Treatment of movement disorders | |
ZA202105111B (en) | Pharmaceutical composition for the treatment of pulmonary arterial hypertension | |
IL291372A (en) | Treatment of chronic granulomatous disease | |
LT3630164T (en) | Dulaglutide for the treatment of chronic kidney disease | |
IL253688A (en) | New compositions and methods of treating and/or preventing chronic obstructive pulmonary disease | |
GB201515244D0 (en) | Treatment of inflammatory disease or condition | |
GB201802353D0 (en) | Treatment of chronic obstructive pulmonary disease | |
GB201802354D0 (en) | Treatment of chronic obstructive pulmonary disease | |
EP3383415A4 (en) | Use of mitochondrial iron chelators for treatment of chronic obstructive pulmonary disease | |
HUE055425T2 (en) | Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbations of chronic obstructive pulmonary disease | |
SG11202006601VA (en) | Methods of treating chronic inflammatory diseases | |
GB201604359D0 (en) | Treatment of tissue disorders | |
GB201811911D0 (en) | Treatment of disease | |
GB201811912D0 (en) | Treatment of disease | |
GB201810974D0 (en) | Treatment of disease | |
GB201809835D0 (en) | Treatment of gastrointestinal disease | |
GB201804603D0 (en) | Treatment of antiretroviral disease | |
GB201915768D0 (en) | Treatment of lung conditions | |
IL272422A (en) | Methods for the treatment of leptomeningeal disease | |
GB201808964D0 (en) | Treatment of liver disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |